Format

Send to

Choose Destination
P T. 2016 Mar;41(3):164-72.

Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults.

Abstract

Naltrexone/bupropion ER (Contrave): newly approved treatment option for chronic weight management in obese adults.

PMID:
26957883
PMCID:
PMC4771085

Supplemental Content

Full text links

Icon for PubMed Central
Loading ...
Support Center